EXPLAINER: Why Elizabeth Holmes’ trial hinges on intent

The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments